This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
AstraZeneca (AZN) Q2 Earnings In Line, Vaccine Aids Sales
by Zacks Equity Research
AstraZeneca (AZN) surpasses second-quarter estimates for revenues while earnings meet estimates. Stock up in pre-market.
Athenex (ATNX) Skin Treatment Klisyri Gets Approval in Europe
by Zacks Equity Research
Athenex (ATNX) announces approval for its skin treatment drug, Klisyri, in Europe. The company's partner Almirall is set to handle the launch of the drug in the region.
Albireo (ALBO) Cholestasis Drug Bylvay Gets European Approval
by Zacks Equity Research
Albireo's (ALBO) Bylvay becomes the first and only drug to treat progressive familial intrahepatic cholestasis, following its approval in Europe.
Strength Seen in Codexis (CDXS): Can Its 12.6% Jump Turn into More Strength?
by Zacks Equity Research
Codexis (CDXS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Codexis (CDXS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Codexis (CDXS) delivered earnings and revenue surprises of 30.00% and 21.09%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Codexis (CDXS) delivered earnings and revenue surprises of 37.50% and 22.85%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Codexis (CDXS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Codexis (CDXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Codexis (CDXS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Codexis (CDXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Company News for Mar 2, 2020
by Zacks Equity Research
Companies in the news are: ALT, BIG, W, CDXS
Codexis (CDXS) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Codexis (CDXS) delivered earnings and revenue surprises of -66.67% and -11.41%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Codexis (CDXS) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Codexis (CDXS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Codexis (CDXS) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Codexis (CDXS) delivered earnings and revenue surprises of 166.67% and 32.32%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Codexis (CDXS) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Codexis (CDXS) delivered earnings and revenue surprises of -100.00% and -17.30%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Codexis (CDXS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Codexis (CDXS) delivered earnings and revenue surprises of 16.67% and 5.06%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Codexis (CDXS) Q4 Earnings Beat Estimates
by Zacks Equity Research
Codexis (CDXS) delivered earnings and revenue surprises of 400.00% and -3.34%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Codexis (CDXS) Reports Break-Even Earnings for Q3
by Zacks Equity Research
Codexis (CDXS) delivered earnings and revenue surprises of 100.00% and 15.81%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Codexis (CDXS) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Codexis (CDXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: AeroVironment, BioSpecifics, Codexis, Avid and American Outdoor
by Zacks Equity Research
The Zacks Analyst Blog Highlights: AeroVironment, BioSpecifics, Codexis, Avid and American Outdoor
5 Top-Ranked Nasdaq Stocks Defying the Worst September Start
by Sweta Killa
There are still winners on the index across industries that are easily surviving the worst start to September and have a solid Zacks Rank #1 (Strong Buy) or 2 (Buy).
E-commerce, Favorable Markets Drive Growth at Grainger (GWW)
by Zacks Equity Research
W.W. Grainger (GWW) will gain from its investment in e-commerce and digital capabilities as well as executing supply chain management actions and efforts to strengthen relationships with customers.
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Codexis (CDXS) delivered earnings and revenue surprises of 83.33% and 14.09%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Cimpress Aims to Mitigate Risks by Decentralizing Operations
by Zacks Equity Research
Cimpress' (CMPR) management has decentralized operations to improve accountability for customer satisfaction and capital returns, simplify decision-making and improve the speed of execution.
Here's Why You Should Add Sonoco (SON) to Your Portfolio Now
by Zacks Equity Research
Sonoco's (SON) prospects remain bright on the back of solid earnings estimate revision activity as well as an upbeat guidance.
What's in Store for KBR Inc. (KBR) this Earnings Season?
by Zacks Equity Research
KBR, Inc. (KBR) is set to report fourth-quarter 2016 results, before the opening bell on Feb 24.
Quanta Services (PWR) Q4 Earnings: What's in the Cards?
by Zacks Equity Research
How are things shaping up for Quanta Services (PWR) fourth-quarter 2016 results slated on Feb 21?